ACADIA PHARMACEUTICALS INC (ACAD) Stock Income Statement
NASDAQ:ACAD - Nasdaq - US0042251084 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 995.97M | 957.80M | 726.44M | 517.20M | 484.10M | |||
| Cost Of Goods | 79.00M | 82.00M | 42.00M | 10.20M | 18.00M | |||
| Gross Profit | 917.08M | 875.96M | 684.80M | 507.10M | 466.10M | |||
| Operating Expenses | 830.00M | 792.00M | 758.00M | 730.60M | 636.60M | |||
| Research and Development | N/A | 303.25M | 351.62M | 361.60M | 239.40M | |||
| Selling, General, and Administrative Expenses | 506.00M | 488.00M | 407.00M | 369.10M | 396.00M | |||
| Operating Income | 88.00M | 84.00M | -73.00M | -223.60M | -170.40M | |||
| Interest Income/Expense | N/A | 25.46M | 17.23M | 6.60M | 600.00K | |||
| Other Income/Expense | 10.55M | 1.82M | 5.11M | 3.50M | 2.30M | |||
| Non Recurring Items | N/A | 147.00M | N/A | N/A | N/A | |||
| Income Before Taxes | 265.00M | 258.00M | -51.00M | -213.40M | -167.50M | |||
| Income Tax | 35.62M | 32.00M | 10.00M | 2.50M | 400.00K | |||
| Net Income | 229.00M | 226.00M | -61.00M | -216.00M | -167.90M | |||
| EBITDA | 98.59M | 99.88M | -67.45M | -221.57M | -167.05M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.37 | 1.36 | -0.37 | -1.34 | -1.05 | |||
| Non GAAP EPS | 0.49 | 0.48 | -0.38 | -0.97 | -1.05 | |||
| Statistics | ||||||||
| Gross Profit Margin | 92.08% | 91.46% | 94.27% | 98.05% | 96.28% | |||
| Profit Margin | 22.99% | 23.60% | -8.40% | -41.76% | -34.68% | |||
| Operating Profit Margin | 8.84% | 8.77% | -10.05% | -43.23% | -35.20% | |||
All data in USD